Is the “8 day rule” for treatment of healthcare-associated pneumonia (HAP) appropriate irrespective of etiologic agent?

Not necessarily.  In fact, an often-quoted study showed more relapses among patients with Pseudomonas aeruginosa nosocomial pneumonia treated for 8 days compared to 15 days, and concluded that the results did not apply to “non-fermenting gram negative bacilli” (1).

For methicillin-resistant Staphylococcus aureus (MRSA) pneumonia, the data on the effectiveness of the shorter course therapy is also quite limited (1,2) .  So for patients with pneumonia due to organisms such as P. aeruginosa or MRSA I decide on the duration of therapy on case-by-case basis depending on the overall stability of the patient and their progress in recovery.

Liked this post? Download the app on your smart phone and sign up below to catch future pearls right into your inbox, all for free!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

References

1. Chastre J, Wolff M, Fagon JY. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:2588-98. 

2. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46 (Suppl5):S378-385.

Is the “8 day rule” for treatment of healthcare-associated pneumonia (HAP) appropriate irrespective of etiologic agent?

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.